Nootropics News Hubb
Advertisement Banner
  • Home
  • News
  • Neuroscience
  • Creative Thinking
  • Food & Supplements
  • Contact
No Result
View All Result
  • Home
  • News
  • Neuroscience
  • Creative Thinking
  • Food & Supplements
  • Contact
No Result
View All Result
Wellnessnewshubb
No Result
View All Result
Home Neuroscience

Investigating Functional Network Abnormalities and Associations With Disability in Multiple Sclerosis

admin by admin
December 1, 2022
in Neuroscience



Background and Objectives

In multiple sclerosis (MS), functional networks undergo continuous reconfiguration and topography changes over the disease course. In this study, we aimed to investigate functional network to pography abnormalities in MS and their association with disease phenotype, clinical and cognitive disability, and structural MRI damage.

Methods

This is a multicenter cross-sectional study. Enrolled participants performed MRI and neurologic and neuropsychological assessment. Network topography was assessed on resting state fMRI data using degree centrality, which counted the number of functional connections of each gray matter voxel with the rest of the brain. SPM12 age-adjusted, sex-adjusted, scanner-adjusted, framewise displacement, and gray matter–volume adjusted analysis of variance and multivariable regressions were used (p < 0.05, family-wise error [FWE] corrected).

Results

We enrolled 971 patients with MS (624 female patients; mean age = 43.1 ± 11.8 years; 47 clinically isolated syndrome [CIS], 704 relapsing-remitting MS [RRMS], 145 secondary progressive MS [SPMS], and 75 primary progressive MS [PPMS]) and 330 healthy controls (186 female patients; mean age = 41.2 ± 13.3 years). Patients with MS showed reduced centrality in the salience and sensorimotor networks as well as increased centrality in the default-mode network vs controls (p < 0.05, FWE). Abnormal centrality was already found in CIS vs controls and in RRMS vs CIS (p < 0.001, uncorrected); however, it became more severe in SPMS vs RRMS (p < 0.05, FWE) and in PPMS vs controls (p < 0.001, uncorrected). Cognitively impaired patients (39%) showed reduced centrality in the salience network and increased centrality in the default-mode network vs cognitively preserved patients (p < 0.001, conjunction analysis). More severe disability correlated with increased centrality in the right precuneus (r = 0.18, p < 0.05 FWE). Higher T2 lesion volume and brain/gray matter atrophy were associated with reduced centrality in the bilateral insula and cerebellum (r = range –0.17/–0.15 and 0.26/0.28, respectively; p < 0.05, FWE). Higher brain/gray matter atrophy was also associated with increased centrality in the default-mode network (r = range –0.31/–0.22, p < 0.05, FWE).

Discussion

Patients with MS presented with reduced centrality in the salience and primary sensorimotor networks and increased centrality in the default-mode network. Centrality abnormalities were specific for different disease phenotypes and associated with clinical and cognitive disability, hence suggesting that voxel-wise centrality analysis may reflect pathologic substrates underpinning disability accrual.



Source link

Previous Post

Responses to dichotic tone-in-noise stimuli in the inferior colliculus

Next Post

13 Reasons Your Husband Gets Angry Over Small Things

Next Post

13 Reasons Your Husband Gets Angry Over Small Things

Recommended

65 Sleep Affirmations for a Restful Night and Better Tomorrow

2 months ago

Reliability of MUSE 2 and Tobii Pro Nano at capturing mobile application users’ real-time cognitive workload changes

2 months ago

Flour Alternatives You Can Use For All Types of Cooking

2 weeks ago

Start the New Year Right: 44 Ideas for a Great Year

2 months ago

Finding Common Ground on the Site of Onset of Amyotrophic Lateral Sclerosis

2 months ago

A review of the circuit-level and cellular mechanisms contributing to locomotor acceleration in the marine mollusk Clione limacina

1 month ago

© 2022 Nootropics News Hubb All rights reserved.

Use of these names, logos, and brands does not imply endorsement unless specified. By using this site, you agree to the Privacy Policy and Terms & Conditions.

Navigate Site

  • Home
  • News
  • Neuroscience
  • Creative Thinking
  • Food & Supplements
  • Contact

Newsletter Sign Up.

No Result
View All Result
  • Home
  • News
  • Neuroscience
  • Creative Thinking
  • Food & Supplements
  • Contact

© 2022 Nootropics News Hubb All rights reserved.